AIB GROUP PLC EUR 2.47 ORDINARY SHARES (OTCMKTS:AIBRF) had a decrease of 0.01% in short interest. AIBRF’s SI was 687,300 shares in May as released by FINRA. Its down 0.01% from 687,400 shares previously. With 1,400 avg volume, 491 days are for AIB GROUP PLC EUR 2.47 ORDINARY SHARES (OTCMKTS:AIBRF)’s short sellers to cover AIBRF’s short positions. The SI to AIB GROUP PLC EUR 2.47 ORDINARY SHARES’s float is 0.03%. It closed at $6.07 lastly. It is down 0.00% since May 17, 2017 and is . It has underperformed by 11.55% the S&P500.
Stock analysts at Barclays began coverage on Udg Healthcare Public Limited Company (LON:UDG) with a “Equal-weight” rating. The target price per share for UDG is set to GBX 875.00. It means a potential downside of -5.91% from company’s stock close price.
AIB Group PLC provides banking and financial services and products to individuals, businesses, and corporate clients primarily in the Republic of Ireland and the United Kingdom. The company has market cap of $16.61 billion. The firm offers various deposit products, such as current accounts, demand deposits, regular saver deposits, notice deposits, fixed term deposits, junior/student saver deposits, and currency deposits. It has a 12.46 P/E ratio. It also provides a range of loans, including personal, car, home improvement, travel, education, wedding, and overdraft loans, as well as graduate finance, mortgages, corporate finance, asset finance, business loans, energy efficiency finance, farmer credit line, farm development loans, forestry finance, invoice finance, prompt pay and insurance premium finance, SBCI loans, startup loans, farm investment loans, debt finance, venture capital finance, and trade finance.
UDG Healthcare plc, together with its subsidiaries, provides clinical, commercial, communication, and packaging services to the healthcare industry in the Republic of Ireland, the United Kingdom, North America, and continental Europe. The company has market cap of 2.31 billion GBP. It operates through three divisions: Ashfield, Sharp, and Aquilant. It has a 32.24 P/E ratio. The Ashfield segment offers commercialization and clinical services for the pharmaceutical and healthcare industry that comprise supporting healthcare professionals and patients at various stages of the product life cycle, as well as provides field and contact center sales teams, healthcare communications, patient support, audit, advisory, medical information, and event management services to approximately 300 healthcare companies.